Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating Severe Brain-Injured Patients With Apomorphine
2023-504631-40-01Phase 2Authorised
- Sponsor
- University of Liège
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2 trial of apomorphine in disorder of consciousness (DOC) and traumatic brain injury (TBI) (2 arms), sponsored by University of Liège. Primary endpoint: Change of diagnosis from baseline in Coma Recovery Scale - Revised (CRS-R). Planned start Sep 2018; status: authorised.
02
Drugs
apomorphine
03
Conditions
disorder of consciousness (DOC)traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2023-504631-40-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504631-40-01.